Medical technology company Becton Dickinson's CR Bard unit faces a bellwether trial in Ohio over its Ventralight hernia mesh, one of 13,000 cases consolidated in a sweeping multi-district litigation. And Sprint tries to dismiss a suit alleging it overstated its growth prospects ahead of its merger with T-Mobile.
